Search

Your search keyword '"Trigatti BL"' showing total 66 results

Search Constraints

Start Over You searched for: Author "Trigatti BL" Remove constraint Author: "Trigatti BL"
66 results on '"Trigatti BL"'

Search Results

1. Characterization of Proliferating Lesion-Resident Cells During All Stages of Atherosclerotic Growth.

2. Interleukin-15 modulates adipose tissue by altering mitochondrial mass and activity.

4. Small molecules targeting GRP78 mitigate anti-GRP78 autoantibody-mediated tissue factor procoagulant activity in cultured endothelial cells.

5. Ligand-dependent interactions between SR-B1 and S1PR1 in macrophages and atherosclerotic plaques.

6. Bystander activated CD8 + T cells mediate neuropathology during viral infection via antigen-independent cytotoxicity.

7. PAR4 Inhibition Reduces Coronary Artery Atherosclerosis and Myocardial Fibrosis in SR-B1/LDLR Double Knockout Mice.

8. Extensive diet-induced atherosclerosis in scavenger receptor class B type 1-deficient mice is associated with substantial leukocytosis and elevated vascular cell adhesion molecule-1 expression in coronary artery endothelium.

9. Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages.

10. Salsalate reduces atherosclerosis through AMPKβ1 in mice.

12. Good Cholesterol Gone Bad? HDL and COVID-19.

13. High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity.

14. Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease.

15. Un-JAMming atherosclerotic arteries: JAM-L as a target to attenuate plaque development.

16. Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner.

17. Hyperglycemia Aggravates Diet-Induced Coronary Artery Disease and Myocardial Infarction in SR-B1-Knockout/ApoE-Hypomorphic Mice.

18. Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice.

19. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.

20. Low-density lipoprotein (LDL)-dependent uptake of Gram-positive lipoteichoic acid and Gram-negative lipopolysaccharide occurs through LDL receptor.

21. Data on leukocyte PDZK1 deficiency affecting macrophage apoptosis but not monocyte recruitment, cell proliferation, macrophage abundance or ER stress in atherosclerotic plaques of LDLR deficient mice .

22. High-density lipoprotein protects cardiomyocytes against necrosis induced by oxygen and glucose deprivation through SR-B1, PI3K, and AKT1 and 2.

23. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.

24. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.

25. Sphingosine-1-Phosphate Receptor 1, Expressed in Myeloid Cells, Slows Diet-Induced Atherosclerosis and Protects against Macrophage Apoptosis in Ldlr KO Mice.

26. Suppression of NK and CD8 + T cells reduces astrogliosis but accelerates cerebellar dysfunction and shortens life span in a mouse model of Sandhoff disease.

27. SR-B1 and PDZK1: partners in HDL regulation.

28. Macrophage Apoptosis and Necrotic Core Development in Atherosclerosis: A Rapidly Advancing Field with Clinical Relevance to Imaging and Therapy.

29. Characterization of Proliferating Lesion-Resident Cells During All Stages of Atherosclerotic Growth.

31. HDL signaling and protection against coronary artery atherosclerosis in mice.

32. Characterization of mice harboring a variant of EPCR with impaired ability to bind protein C: novel role of EPCR in hematopoiesis.

33. Interleukin-15 modulates adipose tissue by altering mitochondrial mass and activity.

34. The effects of diet on occlusive coronary artery atherosclerosis and myocardial infarction in scavenger receptor class B, type 1/low-density lipoprotein receptor double knockout mice.

35. High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists.

36. Deletion of tumor necrosis factor-α ameliorates neurodegeneration in Sandhoff disease mice.

37. SR-BI in bone marrow derived cells protects mice from diet induced coronary artery atherosclerosis and myocardial infarction.

38. The effect of pomegranate extract on coronary artery atherosclerosis in SR-BI/APOE double knockout mice.

39. Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice.

40. Modifications in perfringolysin O domain 4 alter the cholesterol concentration threshold required for binding.

41. Modulators of Protein Kinase C Affect SR-BI-Dependent HDL Lipid Uptake in Transfected HepG2 Cells.

42. A role for the scavenger receptor, class B type I in high density lipoprotein dependent activation of cellular signaling pathways.

43. Interleukin-15 contributes to the regulation of murine adipose tissue and human adipocytes.

44. A point mutation in the neu1 promoter recruits an ectopic repressor, Nkx3.2 and results in a mouse model of sialidase deficiency.

45. Myocardial infarction following atherosclerosis in murine models.

46. The inhibition of endocytosis affects HDL-lipid uptake mediated by the human scavenger receptor class B type I.

47. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells.

48. Cholesterol depletion inhibits fatty acid uptake without affecting CD36 or caveolin-1 distribution in adipocytes.

49. Regulation of SR-BI-mediated selective lipid uptake in Chinese hamster ovary-derived cells by protein kinase signaling pathways.

50. Hepatic high-density lipoprotein receptors: roles in lipoprotein metabolism and potential for therapeutic modulation.

Catalog

Books, media, physical & digital resources